A protocol for pretreatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions.

Authors :: Della Marta, Nicholas
Yuile, Alexander
Mok, Claire
Wei, Joe
Oatley, Meredith
Skinner, Tracey
Miller, Samuel
van Nunen, Sheryl
Clarke, Stephen John
Diakos, Connie Irene
De Silva, Madhawa
Chan, David
Marx, Gavin M.
Pavlakis, Nick
Source :: Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, p115-115, 307p
Publication Year :: 2025

Full Text Access

Tools